Literature DB >> 8404973

Reduction in the risk of bronchopulmonary dysplasia from 1980-1990: results of a multivariate logistic regression analysis.

J D Corcoran1, C C Patterson, P S Thomas, H L Halliday.   

Abstract

A retrospective analysis (1980-1990) of normally formed low birthweight (< 2500 g) infants surviving to at least 28 days following intermittent positive pressure ventilation (IPPV) for longer than 12 h was performed. Bronchopulmonary dysplasia (BPD) was defined as oxygen dependency at 28 days with characteristic radiographic findings. Logistic regression analysis of risk factors, before and after the initiation of IPPV was performed on 412 infants. Decreasing birth weight (BW) and gestational age (GA) were associated with an increased risk of BPD. When controlled for these variables, predictive factors prior to IPPV were gender, age at IPPV, respiratory diagnosis, and year of birth. Following IPPV, duration of peak inspiratory pressure > 25 cm H2O, duration of fraction of inspired oxygen (FiO2) > 0.60 (DO2), maximum peak inspiratory pressure (MPIP), maximum FiO2, patent ductus arteriosus, bacteraemia and either pneumothorax or pulmonary interstitial emphysema were associated with an increased risk of BPD. Adjusting for BW and GA, there was a significant reduction in BPD risk from 1980-1990 (relative odds of 0.88 for each year compared to the previous year). This trend could be largely accounted for by decreases in MPIP and DO2 during the study period. Surfactant treatment was not independently associated with a significant change in the risk of BPD. Based on this analysis, we developed a scoring system for predicting the risk of BPD in the neonatal period which we evaluated in a random sample of infants. This predicted infants at risk of BPD with a sensitivity of 65% and a specificity of 88%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8404973     DOI: 10.1007/bf01955247

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Basic principles of ROC analysis.

Authors:  C E Metz
Journal:  Semin Nucl Med       Date:  1978-10       Impact factor: 4.446

2.  Development and validation of an index for scoring baseline respiratory disease in the very low birth weight neonate. Severity Index Development and Validation Panels and Newborn Lung Project.

Authors:  M Palta; D Gabbert; D Fryback; I Widjaja; M E Peters; P Farrell; J Johnson
Journal:  Pediatrics       Date:  1990-11       Impact factor: 7.124

Review 3.  Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

Authors:  A Greenough
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

4.  Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials.

Authors:  R A Sinkin; C Cox; D L Phelps
Journal:  Pediatrics       Date:  1990-11       Impact factor: 7.124

5.  Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.

Authors: 
Journal:  Pediatrics       Date:  1988-11       Impact factor: 7.124

6.  Chronic lung disease in a neonatal intensive care unit: 8 years experience.

Authors:  B Lupton; H Halliday; P Thomas; G McClure; M M Reid
Journal:  Ir Med J       Date:  1987-09

7.  Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation.

Authors:  R Nilsson; G Grossmann; B Robertson
Journal:  Pediatr Res       Date:  1978-04       Impact factor: 3.756

8.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

9.  Is chronic lung disease in low birth weight infants preventable? A survey of eight centers.

Authors:  M E Avery; W H Tooley; J B Keller; S S Hurd; M H Bryan; R B Cotton; M F Epstein; P M Fitzhardinge; C B Hansen; T N Hansen
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

10.  Factors associated with chronic lung disease in preterm infants.

Authors:  R W Cooke
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

View more
  10 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?

Authors:  A E Harling; M W Beresford; G S Vince; M Bates; C W Yoxall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-29       Impact factor: 5.747

3.  Pulmonary artery pressure: early predictor of chronic lung disease in preterm infants.

Authors:  N V Subhedar; A H Hamdan; S W Ryan; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

4.  Prediction of chronic lung disease (CLD)

Authors:  J D Corcoran; H L Halliday
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

5.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Authors:  Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh
Journal:  Am J Respir Crit Care Med       Date:  2011-03-04       Impact factor: 21.405

6.  Scoring method for early prediction of neonatal chronic lung disease using modified respiratory parameters.

Authors:  Young Don Kim; Ellen Ai-Rhan Kim; Ki Soo Kim; Soo Young Pi; Weechang Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 7.  Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

8.  Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia.

Authors:  P H Gray; Y R Burns; H A Mohay; M J O'Callaghan; D I Tudehope
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

Review 9.  Predictors of bronchopulmonary dysplasia.

Authors:  Andrea Trembath; Matthew M Laughon
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

Review 10.  Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study.

Authors:  Wes Onland; Thomas P Debray; Matthew M Laughon; Martijn Miedema; Filip Cools; Lisa M Askie; Jeanette M Asselin; Sandra A Calvert; Sherry E Courtney; Carlo Dani; David J Durand; Neil Marlow; Janet L Peacock; J Jane Pillow; Roger F Soll; Ulrich H Thome; Patrick Truffert; Michael D Schreiber; Patrick Van Reempts; Valentina Vendettuoli; Giovanni Vento; Anton H van Kaam; Karel G Moons; Martin Offringa
Journal:  BMC Pediatr       Date:  2013-12-17       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.